TABLE 2.
Performance of the 11/25 and/or net charge rule for genotypic prediction of CXCR4 coreceptor usage on HIV-1 molecular clonesa
| Genotypic rule(s) | Expected phenotype | No. of clones with indicated phenotype
|
Sens (%) | Spe (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|---|
| R5 | R5X4/X4 | ||||||
| One basic residue at position 11 or 25 | R5X4/X4 | 6 | 30 | 93.8 | 93 | 83.3 | 97.6 |
| No basic residue at position 11 or 25 | R5 | 80 | 2 | ||||
| Net charge of ≥+5 | R5X4/X4 | 6 | 32 | 100 | 93 | 84.2 | 100 |
| Net charge of <+5 | R5 | 80 | 0 | ||||
| One basic residue at position 11 or 25 and net charge of ≥+5 | R5X4/X4 | 0 | 30 | 93.8 | 100 | 100 | 97.6 |
| No concomitant basic residue at position 11 or 25 and net charge of ≥+5 | R5 | 86 | 2 | ||||
Basic residues refer to amino acids R and K. Sens, sensitivity; Spe, specificity; PPV, positive predictive value; NPV, negative predictive value.